Search

everythinglearnresearchcommunity

for

Search:↓

An automated system can predict death risk in thin melanoma by analyzing immune cells.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

The study found that hair fragility in Pili annulati may be caused by cavities and damage within the hair shafts.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Polycaprolactone and barium titanate composites show promise for use in biomedical applications.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The MIRA technique improves cellulite treatment results and patient satisfaction.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Patients need better information about the risks of long-term steroid use.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

A man developed skin issues from cancer medication, which improved with specific treatments.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Consider THPP in patients with muscle weakness and low potassium, as it is often underdiagnosed.

Patients often overestimate their skin type, affecting sun protection and treatment plans.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Idiopathic hypoparathyroidism is rare and can be managed with dihydrotachysterol.